Treating fibrosing cholestatic hepatitis <scp>C</scp> with sofosbuvir and ribavirin: a matched analysis

Abstract

Our results suggest that the use of sofosbuvir and ribavirin is effective and tolerable in liver transplant recipients treated for recurrent FCH. There is a trend of lower sustained viral response, patient survival, and graft survival in the FCH recipients.